KMSmith, If you do some gOogling regarding OFF LABEL prescriptions in the US, you should find that once a Drug is approved by the FDA a Doctor can prescribe it for other indications.."OFF LABEL"
So it may well be readily available for Autism sufferers much sooner than would be the case here in OZ.
Sometimes drugs have really big sales "OFF LABEL". So it is a smart strategy to go for the quickest approval path...
PBT and NEU could both be in the same space here..Hence why NEU chose RETTS and FRAGX and PBT chose Huntingtons Disease..
Would be keen to hear how your research goes.. Just in case things have changed recently.
undervalued?, page-63
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.94 |
Change
-0.200(1.52%) |
Mkt cap ! $1.653B | |||
| Open | High | Low | Value | Volume |
| $13.03 | $13.06 | $12.75 | $7.500M | 581.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2300 | $12.93 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.96 | 2086 | 1 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |